insights_auto
Why is AGIO down 3,10%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
28,76 $
arrow_downward
-3,10%(-0,92) 1D
28,76 $
0,00% (0,00)
bedtimeAfter hours
Closed: 19 նոյ, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
29,93 $
High
30,35 $
Low
28,71 $
Mkt. cap
1,72 մլրդ
Avg. vol.
1,18 մլն
Volume
590,44 հզր
52-wk high
44,07 $
52-wk low
23,02 $
EPS
-6,32 $
Beta
0,66
Shares outstanding
59,81 մլն
No. of employees
540
Open
29,93 $
High
30,35 $
Low
28,71 $
Mkt. cap
1,72 մլրդ
Avg. vol.
1,18 մլն
Volume
590,44 հզր
52-wk high
44,07 $
52-wk low
23,02 $
EPS
-6,32 $
Beta
0,66
Shares outstanding
59,81 մլն
No. of employees
540
News stories
From web sources and news partners
ChartMill
·
53 րոպե առաջ
S&P 500 After-Hours Movers: Nov. 19, 2026
Traders Union
·
54 րոպե առաջ
S&P 500 sees $2 trillion swing and 8.5 percent drop, Peter Tuchman notes
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc